BFEC
ABMD

Benjamin F. Edwards & Company’s Abiomed Inc ABMD Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29
Closed -$7K – 1931
2022
Q3 		$7K Buy
+29
New +$7.83K ﹤0.01% 1489
2021
Q1 		– Sell
-175
Closed -$57K – 1757
2020
Q4 		$57K Sell
175
-2,798
-94% -$774K ﹤0.01% 944
2020
Q3 		$824K Buy
2,973
+2,427
+445% +$699K 0.06% 306
2020
Q2 		$132K Buy
546
+3
+0.6% +$602 0.01% 664
2020
Q1 		$79K Buy
543
+292
+116% +$48.5K 0.01% 756
2019
Q4 		$43K Buy
251
+217
+638% +$40.2K ﹤0.01% 1011
2019
Q3 		$6K Sell
34
-83
-71% -$17.9K ﹤0.01% 1556
2019
Q2 		$30K Sell
117
-13
-10% -$3.45K ﹤0.01% 1059
2019
Q1 		$37K Buy
130
+22
+20% +$7.31K ﹤0.01% 958
2018
Q4 		$35K Sell
108
-73
-40% -$25.4K ﹤0.01% 936
2018
Q3 		$81K Sell
181
-129
-42% -$50.9K 0.01% 741
2018
Q2 		$127K Buy
310
+110
+55% +$39.9K 0.01% 612
2018
Q1 		$58K Sell
200
-50
-20% -$12.7K 0.01% 812
2017
Q4 		$47K Buy
250
+190
+317% +$35.5K ﹤0.01% 822
2017
Q3 		$10K Buy
+60
New +$9.07K ﹤0.01% 1172

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Benjamin F. Edwards & Company's ABMD Position: Q4 2022 in Review

Benjamin F. Edwards & Company sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 29 shares — an estimated $7K sold.

Benjamin F. Edwards & Company first reported a position in ABMD in Q3 2017 and held it in 15 quarters. The position peaked at $824K in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Benjamin F. Edwards & Company reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 29 Abiomed Inc shares in Q4 2022, an estimated $7K.
  • Benjamin F. Edwards & Company first reported a position in Abiomed Inc in Q3 2017 and held it in 15 quarters.
  • Benjamin F. Edwards & Company's Abiomed Inc position peaked at $824K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2022, filed 7 Feb 2023.